Literature DB >> 18923731

Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.

Pierre Côté1, Jean-Guy Baril, Marie-Nicole Hébert, Marina Klein, Richard Lalonde, Marc Poliquin, Danielle Rouleau, Rachel Therrien, Sylvie Vézina, Bernard Willems, Harold Dion, Patrice Junod, Normand Lapointe, Dominic Lévesque, Lyse Pinault, Cécile Tremblay, Benoît Trottier, Sylvie Trottier, Chris Tsoukas, Alain Piché.   

Abstract

Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective antiretroviral therapies have prolonged survival rates for HIV-infected people over the past decade, which have made latent complications of HCV major causes of morbidity and mortality in these patients. Advances in the treatment of HCV (eg, combined pegylated interferon and ribavirin) offer the possibility of eradicating HCV infection in coinfected persons. The treatment of HCV must be considered in all cases. Intensive management of the adverse effects of HCV treatment is one of the factors for the success of these therapies. HCV eradication is predicted to decrease the mortality associated with coinfection and reduce the toxicity of HIV treatment.

Entities:  

Keywords:  Antiretrovirals; Coinfection; HIV; Hepatitis C virus; Practical guide

Year:  2007        PMID: 18923731      PMCID: PMC2533563          DOI: 10.1155/2007/631054

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  70 in total

1.  Treatment of acute hepatitis C with interferon alfa-2b.

Authors:  Guido Tocci; Ubaldo Visco-Comandini; Giorgio Antonucci
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

2.  Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.

Authors:  Y Khaliq; K Gallicano; I Seguin; K Fyke; G Carignan; D Bulman; A Badley; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 3.  [Natural history of HCV infection].

Authors:  Jean-Claude Trinchet
Journal:  Gastroenterol Clin Biol       Date:  2002-04

4.  Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study.

Authors:  D L Thomas; S A Villano; K A Riester; R Hershow; L M Mofenson; S H Landesman; F B Hollinger; K Davenny; L Riley; C Diaz; H B Tang; T C Quinn
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

5.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

6.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors:  E Kenny-Walsh
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

7.  Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.

Authors:  J García-Samaniego; M Rodríguez; J Berenguer; R Rodríguez-Rosado; J Carbó; V Asensi; V Soriano
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

8.  Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Authors:  Mark S Sulkowski; David L Thomas; Shruti H Mehta; Richard E Chaisson; Richard D Moore
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

9.  A comparison of fibrosis progression in chronic liver diseases.

Authors:  Thierry Poynard; Philippe Mathurin; Ching-Lung Lai; Dominique Guyader; Renée Poupon; Marie-Hélène Tainturier; Robert P Myers; Mona Muntenau; Vlad Ratziu; Michael Manns; Arndt Vogel; Frédérique Capron; Antonio Chedid; Pierre Bedossa
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

10.  Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects.

Authors:  Mario Regazzi; Renato Maserati; Paola Villani; Maria Cusato; Patrizia Zucchi; Elena Briganti; Rinaldo Roda; Luca Sacchelli; Francesca Gatti; Palma Delle Foglie; Giulia Nardini; Paolo Fabris; Fernanda Mori; Paula Castelli; Lucia Testa
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

View more
  7 in total

1.  Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.

Authors:  Paul Damien James; David Kh Wong
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  HCV co-infection in HIV positive population in British Columbia, Canada.

Authors:  Jane A Buxton; Amanda Yu; Paul H Kim; John J Spinelli; Margot Kuo; Maria Alvarez; Mark Gilbert; Mel Krajden
Journal:  BMC Public Health       Date:  2010-04-29       Impact factor: 3.295

3.  Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection.

Authors:  Swee Lin G Chen Yi Mei; Jodie Burchell; Narelle Skinner; Rosie Millen; Gail Matthews; Margaret Hellard; Gregory J Dore; Paul V Desmond; Vijaya Sundararajan; Alexander J Thompson; Kumar Visvanathan; Joe Sasadeusz
Journal:  J Infect Dis       Date:  2016-06-09       Impact factor: 5.226

4.  Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Authors:  Jim Young; Martin Potter; Joseph Cox; Curtis Cooper; John Gill; Mark Hull; Sharon Walmsley; Marina B Klein
Journal:  CMAJ Open       Date:  2013-09-24

5.  Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China.

Authors:  Di Tian; Lin Li; Yongjian Liu; Hanping Li; Xiaoyuan Xu; Jingyun Li
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

6.  Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, China.

Authors:  Yang Jiao; Xiaoxi Zhang; Chen Wang; Li Li; Jie Liu; Katharine J Bar; Huamian Wei; Yao Hu; Ping Huang; Zhaoli Zeng; Shulin Jiang; Jialiang Du; Yiming Shao; David Metzger; Shuming Li; Liying Ma
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

Review 7.  Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions.

Authors:  Ganesh Dattatraya Saratale; Han-Seung Shin; Surendra Krushna Shinde; Dae-Young Kim; Rijuta Ganesh Saratale; Avinash Ashok Kadam; Manu Kumar; Ali Hassan Bahkali; Asad Syed; Gajanan Sampatrao Ghodake
Journal:  J Pers Med       Date:  2022-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.